Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Virginia Norris"'
Autor:
Exton, Virginia Norris
Publikováno v:
Journal of Indigenous Research
The findings from this case study (Exton, 2008) add to the research on effective teacher education programs. The researcher found six factors which contributed to developing teacher identity among secondary teachers who participated in an American In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8204e2100116470afd31ecce2f7c7a9b
Autor:
João Antonio de Queiroz Oliveira, Darren C. Robertson, Sara Brett, Gerben Bouma, Leigh M. Felton, Kirsty J. Hicks, Virginia Norris, Disala Fernando, Ruth M. Tarzi, Michael Herdman, Stefano Zamuner, Andrew Want, Arpita Choudhury
Publikováno v:
British Journal of Clinical Pharmacology. 83:1976-1990
Aims GSK3050002, a humanized IgG1κ antibody with high binding affinity to human CCL20, was administered in a first-in-human study to evaluate safety, pharmacokinetics (PK) and pharmacodynamics (PD). An experimental skin suction blister model was emp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::604f98ebd1055b20d68cade10a1c8c75
https://doi.org/10.1111/bcp.13286
https://doi.org/10.1111/bcp.13286
Autor:
Martha Tarpay, David S. Pearlman, Virginia Norris, Jane H Bentley, David Miller, Richard Sterling, Rogelio Menendez, Sandra E Kent
Publikováno v:
Allergy and Asthma Proceedings. 35:126-133
Exercise-induced bronchoconstriction (EIB) describes the condition whereby exercise causes airflow obstruction that lasts for up to 90 minutes without treatment. This double-blind, placebo-controlled, five-way crossover study investigated the dose re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a467bb075223270159ac20f7fe63ef
https://doi.org/10.2500/aap.2014.35.3723
https://doi.org/10.2500/aap.2014.35.3723
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 26:581-587
GSK961081 is an inhaled bi-functional molecule with both muscarinic antagonism and β2-agonism (MABA) properties. This randomised, double-blind, double-dummy, crossover study evaluated 14 days treatment with the MABA GSK961081 400 μg and 1200 μg on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da693b1a0e99c19f5ccbe0c2e6336d8
https://doi.org/10.1016/j.pupt.2013.03.015
https://doi.org/10.1016/j.pupt.2013.03.015
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 26:256-264
Vilanterol (VI; GW642444M) is a novel inhaled long-acting β2-agonist with inherent 24 h activity in vitro in development as a combination with the inhaled corticosteroid fluticasone furoate for both COPD and asthma. These studies were conducted to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e2c2e9c74fa02c6e1f7e81f29f287b0
https://doi.org/10.1016/j.pupt.2012.12.001
https://doi.org/10.1016/j.pupt.2012.12.001
Autor:
Kevin Murray Schaab, Jane H Bentley, Jilly F. Evans, Virginia Norris, Christopher D. King, Jeroen van de Wetering de Rooij, John H. Hutchinson, Masanori Yamada, Gretchen Bain, Melissa Rewolinski, Jasmine Eleanor Zunic, Nicholas Simon Stock, Claire Ambery, Angelina M. Santini
Publikováno v:
British Journal of Clinical Pharmacology. 75:779-790
Aim To assess the pharmacokinetics, pharmacodynamics, safety and tolerability of the 5-lipoxygenase-activating protein inhibitor, GSK2190915, after oral dosing in two independent phase I studies, one in Western European and one in Japanese subjects,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed48c706d9ffed6e986b70b0d4910980
https://doi.org/10.1111/j.1365-2125.2012.04386.x
https://doi.org/10.1111/j.1365-2125.2012.04386.x
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 36(2)
Interferon beta-1a (IFNβ-1a) 30 μg weekly by intramuscular (IM) injection is used to treat relapsing forms of multiple sclerosis. We assessed if it can be given safely by inhalation. Twenty-one healthy volunteers inhaled IFNβ-1a 300 μg, formulate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e2deda1d4718602ffc2cc6729a6a03
https://pubmed.ncbi.nlm.nih.gov/26692052
https://pubmed.ncbi.nlm.nih.gov/26692052
Autor:
Alan Blackstock, Virginia Norris Exton
Publikováno v:
Interdisciplinary Approaches to Distance Teaching
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcd75c74fe5c9c82abf7d236445fe8bd
https://doi.org/10.4324/9781315694412-4
https://doi.org/10.4324/9781315694412-4
Autor:
Virginia Norris, Hasan Arshad, Stephen T. Holgate, Barry Miller, Shashank Rohatagi, Duyen Tran, Malcolm Boyce, Lee Choong, Sylvaine Millet, Zoe Corden, Stephane Kirkesseli, Brian P. O'Connor
Publikováno v:
Journal of Allergy and Clinical Immunology. 116:761-767
Background Very late antigen (VLA-4) antagonists have been proposed as potential therapies for diseases in which cell recruitment and accumulation are causative. Asthma, which is characterized by airway inflammation involving the accumulation of eosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a356a6705a43e39e7394adf731c0b67
https://doi.org/10.1016/j.jaci.2005.04.045
https://doi.org/10.1016/j.jaci.2005.04.045